ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

STRO Sutro Biopharma Inc

3.94
0.20 (5.35%)
03 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Sutro Biopharma Inc STRO 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.20 5.35% 3.94 05:58:11
개장가 저가 고가 종가 전일 종가
3.80 3.695 4.01 3.94 3.74
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
30/04/202421:00GLOBESutro Biopharma Announces Initiation of Randomized Portion..
02/04/202419:18GLOBESutro Biopharma Announces Pricing of $75 Million..
26/03/202405:30GLOBESutro Biopharma Reports Full Year 2023 Financial Results,..
08/03/202406:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/03/202406:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202406:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/02/202402:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/02/202420:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/02/202406:27EDGAR2Form 8-K - Current report
10/02/202406:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/02/202406:05GLOBESutro Biopharma to Participate in Upcoming Investor..
01/02/202406:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/01/202407:14EDGAR2Form 144 - Report of proposed sale of securities
08/01/202421:31EDGAR2Form 8-K - Current report
05/01/202406:05GLOBESutro Biopharma Highlights Potential Multi-Cancer..
15/12/202306:05GLOBESutro Biopharma to Host Investor Webcast Highlighting..
12/12/202306:05GLOBESutro Biopharma Announces New Positive Data from the..
05/12/202306:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202306:05GLOBESutro Biopharma to Participate in the JMP Securities..
28/11/202306:05EDGAR2Form 8-K - Current report
28/11/202306:00GLOBEVaxcyte Exercises Option and Enters into Manufacturing..
22/11/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
22/11/202306:05EDGAR2Form 8-K - Current report
22/11/202306:05GLOBESutro Biopharma Promotes Jane Chung to President and Chief..
14/11/202307:18EDGAR2Form S-3 - Registration statement under Securities Act of..
14/11/202306:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202306:30EDGAR2Form 8-K - Current report
14/11/202306:30GLOBESutro Biopharma Reports Third Quarter 2023 Financial..
22/10/202317:25GLOBESutro Biopharma Announces Presentation of Data for..
17/10/202305:05GLOBESutro Demonstrates Meaningful ADC Innovation with Five..
05/10/202305:31EDGAR2Form 8-K - Current report
20/09/202305:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/09/202305:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/09/202321:00GLOBESutro Biopharma Appoints Dr. Hans-Peter Gerber as Chief..
30/08/202321:00GLOBESutro Biopharma to Participate in Upcoming Investor..
30/08/202305:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/08/202305:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/08/202305:46EDGAR2Form 144 - Report of proposed sale of securities
12/08/202305:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202305:31EDGAR2Form 8-K - Current report
11/08/202305:30GLOBESutro Biopharma Reports Second Quarter 2023 Financial..
14/07/202307:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/06/202321:00GLOBESutro Biopharma and Blackstone Announce Royalty Financing..
04/06/202305:00GLOBESutro Biopharma Announces Oral Presentation at ASCO 2023..
31/05/202321:00GLOBESutro Biopharma to Participate in the Jefferies Healthcare..

최근 히스토리

Delayed Upgrade Clock